GEHC GE HealthCare
GE HealthCare (GEHC) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: May 22, 2026 , by Lobo Kevin .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Lobo Kevin | Director | Buy | 10,000 | $64.18 | $641.8K | 14,363 | |
| Hochman Rodney F | Director | Buy | 1,618 | $62.03 | $100.4K | 1,618 | |
| Yang Watkin Phoebe L. | Director | Buy | 1,000 | $63.01 | $63.0K | 13,702 | |
| CULP H LAWRENCE JR | Director | Buy | 80,805 | $61.88 | $5.0M | 151,207 | |
| Stromberg William J | Director | Buy | 1,000 | $61.69 | $61.7K | 15,330 | |
| SACCARO JAMES | Chief Financial Officer | Buy | 3,310 | $60.60 | $200.6K | 87,471 | |
| Arduini Peter J | President and CEO | Buy | 4,169 | $59.93 | $249.8K | 259,424 | |
| Jimenez Frank R | GC & Corporate Secretary | Buy | 1,750 | $60.45 | $105.8K | 93,932 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.